Victory Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239K Buy
9,614
+1,077
+13% +$27.9K ﹤0.01% 2165
2025
Q4
$217K Buy
+8,537
New +$190K ﹤0.01% 2186
2025
Q3
Sell
-31,507
Closed -$504K 2480
2025
Q2
$504K Buy
+31,507
New +$476K ﹤0.01% 2058
2025
Q1
Sell
-45,100
Closed -$1.12M 2501
2024
Q4
$1.12M Sell
45,100
-290,260
-87% -$8.23M ﹤0.01% 1757
2024
Q3
$9.56M Buy
335,360
+22,990
+7% +$678K 0.01% 1120
2024
Q2
$8.25M Sell
312,370
-6,631
-2% -$189K 0.01% 1132
2024
Q1
$10.3M Sell
319,001
-6,533
-2% -$238K 0.01% 1056
2023
Q4
$13.7M Sell
325,534
-47,237
-13% -$1.74M 0.01% 921
2023
Q3
$14.3M Sell
372,771
-205,364
-36% -$4.64M 0.02% 882
2023
Q2
$11M Sell
578,135
-87,650
-13% -$1.63M 0.01% 1007
2023
Q1
$10.3M Buy
+665,785
New +$11.6M 0.01% 1017
2021
Q1
Sell
-6,888
Closed -$318K 2761
2020
Q4
$318K Buy
6,888
+1,073
+18% +$49.6K ﹤0.01% 2266
2020
Q3
$205K Buy
+5,815
New +$175K ﹤0.01% 2281

Other funds holding IMVT